Alnylam Pharmaceuticals Stocks List

Related Stock Lists: Biopharmaceutical Biotechnology Diseases Regulus Therapeutics Therapeutic Gene Modulation Acute Intermittent Porphyria Amyloidosis Astrazeneca Atherosclerosis Beta Thalassemia Coronavirus Cystic Fibrosis Deficiency Genetic Disorders Genetics Glioblastoma Hemoglobinopathies Hemophilia Hepatitis C Virus Infection Hepatocellular Carcinoma
Related Industries: Biotechnology

Recent Signals

Date Stock Signal Type
2020-06-02 EIDX Pocket Pivot Bullish Swing Setup
2020-06-02 EIDX 180 Bullish Setup Bullish Swing Setup
2020-06-02 EIDX 200 DMA Support Bullish
2020-06-02 EIDX Upper Bollinger Band Walk Strength
2020-06-02 PRQR Bollinger Band Squeeze Range Contraction
2020-06-02 PRQR 50 DMA Resistance Bearish
2020-06-02 PRQR NR7 Range Contraction
2020-06-02 PRQR Narrow Range Bar Range Contraction
2020-06-02 RGLS Parabolic Rise Strength
2020-06-02 RGLS Pocket Pivot Bullish Swing Setup

Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.

More about Alnylam Pharmaceuticals